Opendata, web and dolomites

HypoCyclo SIGNED

Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HypoCyclo project word cloud

Explore the words cloud of the HypoCyclo project. It provides you a very rough idea of what is the project "HypoCyclo" about.

release    mixed    tested    reactive    survival    assays    generate    covalent    efficacy    hypocyclo    lasers    solubilize    thanks    agent    decoration    biocompatible    training    synthesis    ora    light    presenting    er    researcher    binding    profile    female    agents    decorated    innovative    loaded    technological    breast    represented    antitumor    3d    give    models    upgrade    chemotherapy    triple    foresees    complete    load    cyclodextrin    photosensitizer    aggressive    population    seeking    tailor    industrial    optics    hypoxia    drug    negative    ros    therapeutic    green    tissue    completely    cancer    bc    20    standard    polymeric    tnbc    unibo    polymers    poor    interstitial    therapies    solid    independent    cyd    alternative    option    multimodal    vitro    encapsulate    guaranteeing    paclitaxel    tumours    operative    cells    demanding    pcx    fiber    oxygen    limited    worldwide    biological    endowed    pdt    photodynamic    protocols    respectively    releasing    2d    combination    feasible    sme    synthetic    insolubility    polymer    cancers    options    species    treatment    supervisor    subtype    successful    outcome    compromises    envisage    nps    nanoparticles    optimal    therapy    situ    keep    cyclolab    water    collaborating    ps    source   

Project "HypoCyclo" data sheet

The following table provides information about the project.

Coordinator
CONSIGLIO NAZIONALE DELLE RICERCHE 

Organization address
address: PIAZZALE ALDO MORO 7
city: ROMA
postcode: 185
website: www.cnr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 257˙209 €
 EC max contribution 257˙209 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-CAR
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2023-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) coordinator 257˙209.00

Map

 Project objective

Among all breast cancers (BC) affecting female population worldwide, 20% is represented by Triple Negative Breast Cancer (TNBC), an aggressive subtype with very limited therapeutic options and poor survival. Seeking for innovative TNBC therapies, HypoCyclo aims at the optimal combination of chemotherapy and photodynamic therapy (PDT). We envisage novel, tailored cyclodextrin (CyD)-based polymeric nanoparticles (NPs) able to load “known” therapeutic agents and decorated with a photosensitizer as well as an Oxygen-Releasing Agent. HypoCyclo focuses on the very effective drug paclitaxel (PCX) presenting several treatment problems like water insolubility. Biocompatible, novel CyD polymers are expected to solubilize and encapsulate through non-covalent binding the drug of choice in order to implement PCX chemotherapy with PDT, through the decoration with a PS able to generate antitumor reactive oxygen species (ROS) in situ. Indeed, PDT has become a very challenging yet feasible option thanks to the technological advances in lasers and fiber-optics allowing interstitial and intra-operative light delivery for the treatment of solid tumours, including BC. Finally, as hypoxia in BC tissue compromises standard chemotherapy and PDT, we will tailor our NPs with an ORA able to release oxygen in cells, enabling an alternative ROS source. The PCX loaded NPs will be completely characterized and tested in 2D and 3D TNBC models. Our goal is to keep the synthetic protocols simple, low-cost and green to facilitate industrial upgrade of the loaded multimodal NPs endowed with improved in vitro efficacy. Two partners, the SME Cyclolab and UNIBO, both already collaborating with the supervisor, will give the necessary support in mixed-CyD polymer synthesis and in the biological assays, respectively, guaranteeing a successful outcome. The project foresees a demanding training program for ER that will help him to become an independent researcher with a complete profile.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYPOCYCLO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYPOCYCLO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

ICARUS (2020)

Information Content of locAlisation: fRom classical to qUantum Systems

Read More  

Mel.Photo.Protect (2019)

Unraveling the Photoprotecting Mechanism of Melanin - From a Library of Fragments to Simulation of Spectra and Function

Read More  

ReSOLeS (2019)

New Reconfigurable Spectrum Optical Fibre Laser Sources

Read More